altRx vs bmiMD: which GLP-1 program is better?
altRx and bmiMD are both telehealth GLP-1 programs, but they differ on price, medications, shipping and how you pay. Here's the side-by-side, with the numbers, so you can pick the right one.
Short answer: altRx is our pick in this matchup — lowest compounded entry price and brand-name options under one roof. Consider bmiMD instead if its strength — gLP-1 alongside a peptide and longevity menu, with ready-to-ship inventory — matters more to you.
Educational, not medical advice. This page explains GLP-1 medications in general terms. Only a licensed clinician who knows your history can decide what's right for you.
altRx is our pick in this matchup — lowest compounded entry price and brand-name options under one roof. Consider bmiMD instead if its strength — gLP-1 alongside a peptide and longevity menu, with ready-to-ship inventory — matters more to you.
View Plan: altRxBest for: Lowest entry price + brand option
Choose altRx if…
you want altRx's edge — lowest compounded entry price and brand-name options under one roof.
Best for: GLP-1 telehealth
Choose bmiMD if…
you want bmiMD's edge — gLP-1 alongside a peptide and longevity menu, with ready-to-ship inventory.
Cost breakdown
The numbers that actually decide it, side by side.
| Starting price | $89/mo (compounded semaglutide) | $119/mo (compounded semaglutide) |
|---|---|---|
| Semaglutide | $89/mo (compounded) | $119/mo (compounded; list $228.60) |
| Tirzepatide | From $149/mo (compounded GLP-1 + GIP) | Not a featured product |
| Offering | Both | Compounded |
| Shipping | Included | Included; 'Ready to Ship' in-stock inventory |
| Insurance | Cash; Buy Now, Pay Later available | Cash |
On price, altRx lists $89/mo (compounded) for compounded semaglutide and From $149/mo (compounded GLP-1 + GIP) for tirzepatide, while bmiMD lists $119/mo (compounded; list $228.60) and Not a featured product. Where prices are published, altRx is the lower-cost option.
Both are cash-pay compounded programs, so the real decision comes down to price, shipping, pharmacy credentials and support rather than the drug itself.
Full specs, side by side
| Why choose it | Lowest compounded entry price and brand-name options under one roof | GLP-1 alongside a peptide and longevity menu, with ready-to-ship inventory |
|---|---|---|
| Watch out for | As with any compounded product, quality rests on the pharmacy | Semaglutide starts at $119/mo — above the cheapest cash options; tirzepatide isn't featured |
| Starting price | $89/mo (compounded semaglutide) | $119/mo (compounded semaglutide) |
| Compounded semaglutide | $89/mo (compounded) | $119/mo (compounded; list $228.60) |
| Tirzepatide | From $149/mo (compounded GLP-1 + GIP) | Not a featured product |
| GLP-1 + GIP option | Yes — compounded tirzepatide (GLP-1 + GIP) from $149/mo | Not listed |
| Offering type | Both | Compounded |
| New-patient offer | Buy Now, Pay Later financing available | Sale pricing $119/mo (from $228.60) |
| Billing model | Monthly plans; multi-month options | Monthly plans |
| What's included | Online medical evaluation, Medication, Shipping, Dose adjustments | Online medical evaluation, Medication, Shipping |
| Lab work | Online intake; labs may be requested for some patients | Online intake |
| Shipping | Included | Included; 'Ready to Ship' in-stock inventory |
| Refills | Monthly refills | Monthly refills |
| States | Most US states | US telehealth |
| Pharmacy | US compounding pharmacies (503A); brand via licensed pharmacies | US compounding pharmacies |
| Clinicians | US-licensed prescribers | US-licensed prescribers |
| Insurance | Cash; Buy Now, Pay Later available | Cash |
| Consultation | Asynchronous online medical intake | Online medical intake |
| Our rating | 9.6 · Excellent | 8.7 · Very Good |
Medications & formulations
- altRx: both GLP-1. Yes — compounded tirzepatide (GLP-1 + GIP) from $149/mo
- bmiMD: compounded GLP-1. Not listed
New to the drugs themselves? Read our plain-language guides to semaglutide and tirzepatide.
Pros & cons
Pros
- Lowest published compounded entry price in our list
- Rare option to choose compounded OR brand-name in one place
- Buy Now, Pay Later spreads the cost
- No insurance needed to start
Cons
- Compounded products aren't FDA-approved finished drugs
- Brand-name pricing depends on insurance/eligibility
Pros
- Transparent list-vs-sale pricing shown upfront
- Ready-to-ship inventory for fast dispatch
- One clinic for GLP-1 plus peptide and longevity therapies
- No insurance required to start
Cons
- Compounded semaglutide entry ($119/mo) is higher than the cheapest cash programs
- Compounded tirzepatide isn't a featured option
- Compounded products aren't FDA-approved finished drugs
Where each one has the edge
We don't tally a winner — that hides the trade-offs. Here's who leads on each dimension and why.
altRx: $89/mo (compounded). bmiMD: $119/mo (compounded; list $228.60).
altRx offers both; bmiMD offers compounded.
altRx: Included. bmiMD: Included; 'Ready to Ship' in-stock inventory.
Comparable pharmacy disclosures.
Both are primarily cash-pay for compounded GLP-1.
Match by your priority
The fastest way to decide: find your top priority, see which program we'd point you to.
If your priority is the lowest published price
If your priority is the best shipping
If your priority is our overall pick
altRx vs bmiMD: common questions
The bottom line
altRx is our pick in this matchup — lowest compounded entry price and brand-name options under one roof. Choose bmiMD only if its strength (gLP-1 alongside a peptide and longevity menu, with ready-to-ship inventory) matters more to you than price and our overall rating.
How we compare — and how to read this
We compare programs on the factors that actually affect a patient: real price (including whether it's compounded or branded), medications and formulations offered, shipping, pharmacy accreditation and clinician model, insurance stance, and commitment. We name a top pick for most people, but we show the trade-offs in full so you can override it when your priorities or insurance point the other way. Pricing is provider-reported and changes frequently — and compounded-drug availability shifts with FDA shortage status — so always confirm the current details on the provider's own site before enrolling. Affiliate relationships do not change a program's placement. This page is educational and not medical advice; see our disclaimer.
Not sure which one is right for you?
Answer 7 quick questions and we'll match you to a program.
Take the match quiz